![Ciplas COVID-19 Drug Cipremi To Cost Less Than Rs 5,000 Per Vial Ciplas COVID-19 Drug Cipremi To Cost Less Than Rs 5,000 Per Vial](https://thelogicalindian.com/h-upload/2020/06/25/500x300_175795-photo2020-06-2513-44-27-2.jpg)
Latest News
Cipla's COVID-19 Drug 'Cipremi' To Cost Less Than Rs 5,000 Per Vial
Indian drugmaker Cipla Ltd will price 'Cipremi', the generic version of US-based Gilead Science Inc's antiviral drug Remdesivir for COVID-19 patients at less than ₹5,000 ($66) per 100mg vial. Gilead Science Inc extended a voluntary non-exclusive license to Cipla to manufacture and market the...